G. Monfette

New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens

Fernand Labrie, A. Dupont, A. Bèlanger et al. · The Prostate · 1983 · 292 citations

New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.

Fernand Labrie, A. Dupont, A. Bèlanger et al. · PubMed · 1982 · 274 citations

Medical Castration, Urology, Prostatic Cancer +15

Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survival

Fernand Labrie, A. Dupont, A. Bèlanger et al. · Journal of Steroid Biochemistry · 1985 · 154 citations

Surgical Oncology, Oncology, Urology +9

Benefits of Combination Therapy with Flutamide in Patients Relapsing after Castration

Fernand Labrie, A. Dupont, M. Giguère et al. · British Journal of Urology · 1988 · 70 citations

Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer.

Fernand Labrie, A. Dupont, A. Bélanger et al. · Proceedings of the National Academy of Sciences · 1984 · 64 citations · Full text

Simultaneous Administration, Urology, Oncology +13